Monitoring Pulmonary Artery Pressure by Implantable Device Responding to Ultrasonic Signal (PAPIRUS III)

Observation Study With Implantable Medication Pump for Intravenous Treprostinil Therapy in Patients With Pulmonary Arterial Hypertension

NCT04309838 ·Status: UNKNOWN

(RIGHT HEART III Study - Right Ventricular Hemodynamic Evaluation and Response to Treatment)

NCT03362047 ·Status: COMPLETED ·Phase: PHASE2

Combination Therapy in Pulmonary Arterial Hypertension

NCT00433329 ·Status: COMPLETED ·Phase: PHASE4

LenusPro Pump in PAH Treated With Treprostinil

NCT02889315 ·Status: UNKNOWN

Feasibility of Slow-paced Respiration Therapy for Treatment of a Symptom Cluster in Pulmonary Arterial Hypertension

NCT02080533 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

A Study to Learn About the Study Medicine (Called PF-07868489) in People With Pulmonary Arterial Hypertension Who Have Previously Participated in a Clinical Study With PF-07868489

NCT07073820 ·Status: RECRUITING ·Phase: PHASE2

A Multinational, Multicenter, Study to Assess the Efficacy and Safety of BPS-314d-MR in Subjects With Pulmonary Arterial Hypertension Currently Receiving Treatment With an Endothelin Receptor Antagonist and/or a Phosphodiesterase-5 Inhibitor

NCT01458236 ·Status: WITHDRAWN ·Phase: PHASE3

A Trial of "APL-9796'' in Adults With Pulmonary Hypertension

NCT06846554 ·Status: RECRUITING ·Phase: PHASE2

Study of Safety and Efficacy of ALT-100mAb in Participants With Moderate/Severe ARDS

NCT05938036 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

SIRIUS - Initial Combination Therapy With an Endothelin Receptor Antagonist, a Phosphodiesterase-5 Inhibitor and Sotatercept in Patients With Newly Diagnosed Pulmonary Arterial Hypertension

NCT07266519 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

Point of Care Ultrasonography Assessment During Pulmonary Hypertension Clinic

NCT05332847 ·Status: COMPLETED ·Phase: NA

Patient Global Impression Questions for Activity-Induced Symptoms in Participants With PAH

NCT03888365 ·Status: COMPLETED

A Multi-Center, Open-Label, Multiple Dose, Dose Finding Study Exploring the Safety and Tolerability of Beraprost Sodium Modified Release in PAH Patients

NCT00781885 ·Status: COMPLETED ·Phase: PHASE2

Effect iNO on Functional Respiratory Imaging in Subjects With WHO Group 3 Pulmonary Hypertension With COPD on Oxygen

NCT03135860 ·Status: TERMINATED ·Phase: EARLY_PHASE1

ARIES - Ambrisentan in Patients With Moderate to Severe Pulmonary Arterial Hypertension (PAH)

NCT00091598 ·Status: COMPLETED ·Phase: PHASE3

VentaProst Versus Conventionally-Administered Aerosolized Epoprostenol in Patients Undergoing Cardiac Surgery With CPB

NCT03122730 ·Status: COMPLETED ·Phase: PHASE2

Effects of the Combination of Bosentan and Sildenafil Versus Sildenafil Monotherapy on Pulmonary Arterial Hypertension (PAH)

NCT00303459 ·Status: COMPLETED ·Phase: PHASE4

Dose-response Study of the Safety and Efficacy of Beraprost Sodium Modified Release (BPS-MR) in Patients With Pulmonary Arterial Hypertension (PAH)

NCT00989963 ·Status: COMPLETED ·Phase: PHASE2

Efficacy and Safety of Upfront Combination of ΒΟsentan and ΤΑdalafil in Pulmonary Arterial Hypertension

NCT03139084 ·Status: WITHDRAWN

Real-World Study of PADN for the Treatment of PAH

NCT07039604 ·Status: RECRUITING

ARTEMIS-PH - Study of Ambrisentan in Subjects With Pulmonary Hypertension Associated With Idiopathic Pulmonary Fibrosis

NCT00879229 ·Status: TERMINATED ·Phase: PHASE3

Efficacy and Safety of Seralutinib in Adult Subjects With PAH (PROSERA)

NCT05934526 ·Status: COMPLETED ·Phase: PHASE3

An Open-Label Extension of BPS-MR-PAH-201 in Pulmonary Arterial Hypertension (PAH) Patients

NCT00792571 ·Status: COMPLETED ·Phase: PHASE2

Evaluation of the Pulmonary Vascular Reactivity Test in Patients With Pulmonary Arterial Hypertension and a Cardiac Shunt

NCT02138708 ·Status: WITHDRAWN ·Phase: NA

Treatment of PH With Angiotensin II Receptor Blocker and Neprilysin Inhibitor in HFpEF Patients With CardioMEMS Device

NCT04753112 ·Status: COMPLETED ·Phase: PHASE3